The Age-Related Macular Degeneration (AMD) Market has witnessed significant growth in recent years, The global burden of AMD continues to rise at an unprecedented speed as the global population grows and the demographics reflect a majority of older people. AMD is a primary cause of visual loss in the elderly, according to the National Eye Institute. Furthermore, those over the age of 60 are at a higher risk of having the condition. Our comprehensive research report titled Age-Related Macular Degeneration (AMD) market offers a thorough analysis of the current market landscape and sheds light on the market trends, competitive dynamics, and growth opportunities. Also, it identifies the top players in the market and assesses their offerings, strategies, market share, and performance to help stakeholders make informed decisions and stay ahead of the competition.
Market Overview:
According to the research report published by Polaris Market Research, the global Age-related Macular Degeneration (AMD) market was valued at USD 7.47 billion in 2021 and is expected to reach USD 14.43 billion by 2030, to grow at a CAGR of 7.9% during the forecast period.
Research Methodology:
Our research methodology combines qualitative and quantitative methods to offer a thorough analysis of the market. These research techniques used include:
Focus Groups: Includes qualitative data and insights into customer attitudes and opinions.
Surveys: Offers insights into consumer behavior, opinion, and interests.
Interviews: The study covers in-depth conversations with individuals to collect information about attitudes, beliefs, and motivations.
Secondary Research: The report analyzes existing data from reports, publications, and other credible sources.
All the information in the Age-Related Macular Degeneration (AMD) market research report goes through a multi-step verification method to ensure its accuracy and reliability.
List of Market Key Players:
The market has the presence of both established players and new entrants. These players are focusing on innovation and strategic partnerships to expand their global reach and increase their Age-Related Macular Degeneration (AMD) market share. Some of the key players in the market are:
Acucela Inc.
Alimera Sciences Inc.
ALLERGAN
Bausch & Lomb Incorporated
Bayer AG
F. Hoffmann La Roche
GlaxoSmithKline PLC
Novartis AG
Ophthotech Corporation
Pfizer Inc
Regeneron Pharmaceuticals
Rxi Pharmaceuticals Inc.
Santen Pharmaceuticals Co.
Valeant Pharmaceuticals International
Overview of Top Companies:
Acucela Inc.
Acucela Inc., a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd., is dedicated to developing innovative therapies and devices aimed at preserving and restoring vision. The company's research focuses on sight-threatening ophthalmic diseases, including retinitis pigmentosa, proliferative diabetic retinopathy, diabetic macular edema, age-related macular degeneration (AMD), Stargardt disease, cataracts, and presbyopia. Additionally, Acucela is developing a monitoring device for neovascular retinal diseases intended for patient use.
Alimera Sciences Inc.
Alimera Sciences Inc., founded in 2003 and headquartered in Alpharetta, Georgia, is a pharmaceutical company specializing in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. The company focuses on diseases affecting the retina, particularly diabetic macular edema (DME). Alimera's primary product, ILUVIEN, is an intravitreal implant delivering sustained-release fluocinolone acetonide, approved for treating DME and non-infectious uveitis affecting the posterior segment of the eye. In September 2024, ANI Pharmaceuticals, Inc. completed its acquisition of Alimera Sciences.
Browse More Information:
Competitive Landscape:
The competitive landscape of the market is shaped by strategic partnerships and collaborations among Age-Related Macular Degeneration (AMD) market key players. These strategic initiatives are aimed at expanding their product portfolios and expanding their global reach. Companies like Acucela Inc., Alimera Sciences Inc., ALLERGAN, Bausch & Lomb Incorporated, Bayer AG, F. Hoffmann La Roche, GlaxoSmithKline PLC, Novartis AG, Ophthotech Corporation, Pfizer Inc, Regeneron Pharmaceuticals, Rxi Pharmaceuticals Inc., Santen Pharmaceuticals Co., Valeant Pharmaceuticals International are leveraging their global reach to cater to diverse consumer needs across various regions. Other players, such as Acucela Inc., Alimera Sciences Inc., ALLERGAN, Bausch & Lomb Incorporated, Bayer AG, are focusing on the incorporation of advanced technologies to improve their offerings. As the market evolves, the competition is set to intensify in the upcoming years.
Conclusion:
The Age-Related Macular Degeneration (AMD) market growth is poised to continue in the upcoming years. Companies adapting to shifting consumer preferences and technological innovations will continue to thrive in the evolving market landscape.
More Trending Latest Reports By Polaris Market Research:
Automated Breach and Attack Simulation Market
North America Robot Operating System Market
Neurological Biomarkers Market
Write a comment ...